Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
14.74
-0.15 (-1.01%)
Jan 14, 2025, 4:00 PM EST - Market closed
Assembly Biosciences Employees
Assembly Biosciences had 65 employees as of December 31, 2023. The number of employees decreased by 3 or -4.41% compared to the previous year.
Employees
65
Change (1Y)
-3
Growth (1Y)
-4.41%
Revenue / Employee
$435,785
Profits / Employee
-$627,754
Market Cap
93.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ASMB News
- 19 days ago - Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B - GlobeNewsWire
- 6 months ago - Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop - GlobeNewsWire
- 7 months ago - Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 - GlobeNewsWire
- 8 months ago - Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024 - GlobeNewsWire
- 8 months ago - Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 10 months ago - Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 1 year ago - Assembly Biosciences Announces Effective Date of Reverse Stock Split - GlobeNewsWire
- 1 year ago - Assembly Biosciences Provides Anticipated Development Milestones for 2024 - GlobeNewsWire